Geskin, L., Querfeld, C., Hodak, E., Nikbakht, N., Papadavid, E., Ardigò, M., Wehkamp, U., & Bagot, M. (2024). Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians. Dermatology and Therapy. https://doi.org/10.1007/s13555-024-01305-x

Sardar, Z., Kim, C. Y., & Thakur, K. T. (2024). Clinical Characteristics and Risk Factors for Cryptococcal Meningitis in Diverse Patient Populations in New York City. Open Forum Infectious Diseases, 11(10). https://doi.org/10.1093/ofid/ofae576

Olsen, E. A., Hodak, E., Geskin, L., & Scarisbrick, J. (2024). Bridging the specialty gap: Update on primary cutaneous lymphomas. Journal of the American Academy of Dermatology, 90(2), 257–260. https://doi.org/10.1016/j.jaad.2023.10.007

Geskin, L., Querfeld, C., Hodak, E., Nikbakht, N., Papadavid, E., Ardigò, M., Wehkamp, U., & Bagot, M. (2024). Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1298988

Geskin, L. J., Angello, J. T., Bagot, M., Guenova, E., Nikbakht, N., Querfeld, C., & Scarisbrick, J. J. (2024). Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences. Clinical Lymphoma Myeloma and Leukemia, 24(1), 40–47. https://doi.org/10.1016/j.clml.2023.08.020

Youssef, S., & Bordone, L. A. (2023). Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus. JAAD Case Reports, 37, 16–20. https://doi.org/10.1016/j.jdcr.2023.04.017

Geskin, L. J., Kwinta, B. D., Garcia-Saleem, T. J., Akilov, O. E., Enz, P. A., Guenova, E., Ortiz-Romero, P. L., Papadavid, E., Quaglino, P., Rozati, S., Stonesifer, C. J., Burns, A., Stringer, W. S., Tarin, E., & Scarisbrick, J. J. (2023). International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study. Journal of the American Academy of Dermatology, 88(4), 935–937. https://doi.org/10.1016/j.jaad.2022.11.016

Miller, R. C. (2023). A “Solution” for Patients Unable to Swallow a Pill: Crushed Terbinafine Mixed With Syrup. Cutis, 111(3). https://doi.org/10.12788/cutis.0714

Bruckner, A., Tang, J., Chung, W., Morel, K., Chen, M., Woodley, D., Keene, D., Peoples, K., Barriga, M., Carroll, J., Levin, L., Ravindran, S., Mangone, M., Ramsdell, D., & Landy, H. (2022). 295 Collagen 7 (C7) protein replacement therapy (PTR-01) durably reduces wound size and symptoms in patients with recessive dystrophic epidermolysis bullosa (RDEB). Journal of Investigative Dermatology, 142(8), S50. https://doi.org/10.1016/j.jid.2022.05.303

Di Napoli, A., Vacca, D., Bertolazzi, G., Lopez, G., Piane, M., Germani, A., Rogges, E., Pepe, G., Santanelli Di Pompeo, F., Salgarello, M., Jobanputra, V., Hsiao, S., Wrzeszczynski, K. O., Berti, E., & Bhagat, G. (2021). RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K/AKT Signaling via Neurotrophin Pathway Genes. Cancers, 13(24), 6174. https://doi.org/10.3390/cancers13246174